2019-10-10 11:38:39 | Puma Biotechnology falls after Bernie Sanders calls out 20% price hikePuma Biotechnology (PBYI) increased the price of its breast cancer treatment Nerlynx by 20% in nine months, Ed Silverman of STAT News reported yesterday. Today, Presidential candidate and Senator Bernie Sanders responded to a STAT reporter asking if anybody will notice with a tweet saying, "I noticed, and I'm pretty damn sure patients with breast cancer and their families will notice too." Shares of Puma Biotechnology are down 4.5%, or 35c, to $7.30 in late morning trading. Reference Link |
---|